Who
Pamela Garzone
Director
Company insider
Files Form 4 as: Director, Cue Biopharma.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 19 Apr 2023
- Last trade
- 9 Jul 2026
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jul 2026filed 28 Aug 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code A | —18,900 at $0.00 | filing |
| 9 Jul 2026filed 28 Aug 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code A | —18,900 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code A | —21,800 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code A | —21,800 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,400 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,400 at $0.00 | filing |
| 2 Jan 2025filed 3 Jan 2025 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,400 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,400 at $0.00 | filing |
| 19 Apr 2023filed 21 Apr 2023 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.